Table IVB.
Longitudinal results*
| Lesion |
No lesion |
|||||||
|---|---|---|---|---|---|---|---|---|
| PSV | APD | P | PSV | APD | P | |||
| T1ρ longitudinal: baseline and 2 year | Baseline >2 year | MF | 0% | – | – | <1% | – | – |
| MT | 0% | – | – | 0% | – | – | ||
| LF | <1% | – | – | <1% | – | – | ||
| LT | 1.9% | 18.5% | 0.03 | 6.5% | 29.5% | 0.02 | ||
| TrF | 1.0% | 11.5% | 0.03 | 1.9% | 22.3% | 0.03 | ||
| P | <1% | – | – | <1% | – | – | ||
| Baseline <2 year | MF | 12.7% | 14.3% | 0.02 | <1% | – | – | |
| MT | 12.5% | 18.3% | 0.03 | 4.1% | 31.3% | 0.03 | ||
| LF | 14.9% | 15.3% | 0.02 | 9.3% | 24.6% | 0.03 | ||
| LT | 1.5% | 23.5% | 0.03 | <1% | – | – | ||
| TrF | 6.9% | 12.3% | 0.02 | <1% | – | – | ||
| P | 2.4% | 17.8% | 0.02 | <1% | – | – | ||
| T2 longitudinal: baseline and 2 year | Baseline >2 year | MF | <1% | 11.1% | 0.04 | 4.1% | 22.1% | 0.03 |
| MT | 0% | – | – | 0% | – | – | ||
| LF | 13.7% | 18.4% | 0.02 | <1% | – | – | ||
| LT | <1% | – | – | 6.0% | 34.5% | 0.3 | ||
| TrF | 2.3% | 11.1% | 0.02 | <1% | – | – | ||
| P | 6.5% | 25.7% | 0.03 | 5.3% | 26.0% | 0.03 | ||
| Baseline <2 year | MF | 2.1% | 21.5% | 0.02 | 0% | – | – | |
| MT | 17.3% | 27.6% | 0.03 | 2.3% | 28.0% | 0.03 | ||
| LF | 1.6% | 21.8% | 0.02 | <1% | – | – | ||
| LT | 6.2% | 24.8% | 0.03 | 0% | – | – | ||
| TrF | <1% | – | – | <1% | – | – | ||
| P | <1% | – | – | 0% | – | – | ||
P, patella.
Compartments with <1% of PSV do not have APD and P values displayed. Compartments with the largest PSV are bolded.